This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Myeloid leukaemia
CD2_MYELOID_LEUKAEMIA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1006 |
4. Check minimum number of eventsNone |
1006 |
5. Include endpointsNone |
1006 |
6. Filter based on genotype QC (FinnGen only) |
937 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- C81-C96
- Name in latin
- Leuc(h)aemia myeloides
Similar endpoints
↥List of similar endpoints to
Myeloid leukaemia
based on the number of shared cases.
Similar with more cases:
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers, helper endpoint
- Malignant neoplasm
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 937 | 416 | 521 |
| Unadjusted period prevalence (%) | 0.20 | 0.15 | 0.24 |
| Median age at first event (years) | 65.81 | 61.45 | 69.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1006
- Matched controls
- 10060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
307.7
301
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
307.7
628
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
136.4
307.7
770
235
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
307.7
335
*
XW000
NOMESCO Finland
Bone marrow biopsy
59.8
307.7
560
207
WW500
NOMESCO Finland
Blood transfusion
17.5
299.9
274
211
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
20.4
265.1
217
134
L01XX05
ATC
hydroxycarbamide; oral
37.2
256.3
163
52
127
Kela drug reimbursment
Transplant complication
37.1
251.6
160
51
L03AA02
ATC
filgrastim; parenteral
19.2
244.7
205
132
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
106.7
236.7
122
13
M04AA01
ATC
allopurinol; systemic
8.0
229.2
445
912
A05AA02
ATC
ursodeoxycholic acid; oral
33.4
220.0
144
50
189
Kela drug reimbursment
Imatinib
587.8
200.1
192
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
70.1
184.9
101
16
A04AA01
ATC
ondansetron; systemic, rectal
8.6
177.4
269
411
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
67.4
167.3
92
15
L01XE01
ATC
[U] imatinib
620.4
164.0
158
*
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
146.5
137
*
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
55.5
135.2
77
15
L01EA01
ATC
imatinib; oral
458.4
124.7
122
*
L01BB02
ATC
mercaptopurine; oral
31.4
122.8
81
28
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
338.9
120.0
119
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.2
118.0
308
780
R50.9
ICD-10 Finland
Fever, unspecified
5.0
117.9
336
915
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.3
115.5
295
732
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
21.8
113.6
86
43
316
Kela drug reimbursment
Imatinib
1144.7
107.4
103
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
20.5
106.8
83
44
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.9
106.2
185
320
D70.89
ICD-10 Finland
Neutropenic splenomegaly
20.4
104.1
81
43
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.6
104.1
161
245
J05AB11
ATC
valaciclovir; oral
4.7
100.4
297
823
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
27.4
100.1
69
27
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.7
98.6
174
304
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
20.4
95.3
74
39
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
13.4
93.6
91
74
L04AD01
ATC
ciclosporin; systemic
15.9
92.2
81
55
212
Kela drug reimbursment
Gout
12.2
89.3
92
82
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
9.0
87.8
115
143
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
7.5
81.9
126
189
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
430.8
81.1
80
*
D64.9
ICD-10 Finland
Anaemia, unspecified
4.4
79.1
244
687
J01MA12
ATC
levofloxacin; systemic
3.6
77.4
349
1279
WW200
NOMESCO Finland
Immunization
9.9
77.2
92
101
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
36.0
76.1
48
14
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
26.1
74.3
52
21
J02AC03
ATC
voriconazole; systemic
164.2
73.1
76
5
L04AA01
ATC
[U] ciclosporin
16.3
69.6
60
39
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
246.6
68.1
69
*
A41.9
ICD-10 Finland
Sepsis, unspecified
6.6
67.6
117
198
121
Kela drug reimbursment
Severe hypofunction of sexual glands
10.7
63.5
71
71
152
Kela drug reimbursment
Nilotinib
+∞
63.2
60
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
61.1
58
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
60.0
57
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
23.0
59.9
44
20
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
19.2
58.1
46
25
J01MA14
ATC
moxifloxacin; systemic
4.1
57.8
181
508
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
579.0
56.2
55
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
579.0
56.2
55
*
Z51.5
ICD-10 Finland
Palliative care
3.9
51.3
171
500
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
51.1
606
3607
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
50.4
48
*
L01XX28
ATC
[U] imatinib
+∞
50.4
48
*
B73
ICPC
Leukaemia
139.7
50.3
53
*
150
Kela drug reimbursment
Dasatinib
+∞
49.4
47
*
ZX120
NOMESCO Finland
Intravenous
3.7
47.9
172
528
ZX112
NOMESCO Finland
Subcutaneous
7.4
47.1
70
100
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
46.2
44
*
C90.0
ICD-10 Finland
Multiple myeloma
10.9
45.8
50
48
TGC00
NOMESCO Finland
Bronchial lavation
6.6
45.6
76
123
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
45.3
271
1129
H02AB09
ATC
hydrocortisone; systemic
7.8
45.0
64
87
L01XE06
ATC
[U] dasatinib
+∞
42.0
40
*
L04AA06
ATC
mycophenolic acid; systemic
8.7
41.0
53
64
328
Kela drug reimbursment
Nilotinib
+∞
40.9
39
*
L01XE08
ATC
[U] nilotinib
+∞
40.9
39
*
JN4AD
NOMESCO Finland
Body CT examination
3.3
40.0
176
612
J02AC04
ATC
posaconazole; systemic
208.0
39.1
40
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
38.8
37
*
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
38.8
37
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.0
38.5
88
191
L01EA03
ATC
nilotinib; oral
+∞
37.7
36
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
10.2
37.6
43
44
B03XA02
ATC
darbepoetin alfa; parenteral
6.2
37.2
65
110
J05AB01
ATC
aciclovir; systemic
2.6
36.5
281
1314
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.5
35.2
71
138
N02AA05
ATC
oxycodone; systemic
2.5
34.4
271
1277
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
32.5
362
1982
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
327.0
32.0
32
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.2
31.7
90
232
L01XX52
ATC
venetoclax; oral
47.9
30.8
37
8
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.7
30.5
105
310
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
30.4
29
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.5
30.3
78
186
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
60.3
30.3
35
6
D45
ICD-10 Finland
Polycythaemia vera
9.5
30.2
36
39
L04AD02
ATC
tacrolimus; systemic
11.9
29.3
30
26
B03XA01
ATC
erythropoietin; parenteral
9.5
28.4
34
37
324
Kela drug reimbursment
Dasatinib
+∞
28.3
27
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.7
27.5
44
68
2050A
ICD-9 Finland
Myeloid leukaemia, Acute
+∞
27.2
26
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
27.2
160
647
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
32.9
27.0
35
11
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
6.3
26.5
45
74
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
26.0
133
499
H02AB04
ATC
methylprednisolone; systemic
2.5
25.8
188
843
J02AC01
ATC
fluconazole; systemic
2.1
25.4
374
2241
JN6AD
NOMESCO Finland
CT of torso and neck
7.2
24.7
37
53
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
9.6
24.5
29
31
A40.8
ICD-10 Finland
Other streptococcal sepsis
8.4
24.5
32
39
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.5
24.1
40
64
D70.82
ICD-10 Finland
Drug-induced neutropenia
6.2
23.9
41
68
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.8
23.7
30
35
WW409
NOMESCO Finland
Other aferesis
42.5
23.7
29
7
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
128.1
23.7
25
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
23.6
108
380
A41.8
ICD-10 Finland
Other specified sepsis
5.3
23.5
48
94
C92.2
ICD-10 Finland
Atypical chronic myeloid leukaemia, BCR/ABL- negative
+∞
23.0
22
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
22.9
300
1709
L03AB05
ATC
interferon alfa-2b; parenteral
28.1
22.3
30
11
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.3
22.0
58
141
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
22.0
21
*
L01EA02
ATC
dasatinib; oral
+∞
22.0
21
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
25.7
21.8
30
12
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
21.8
131
533
399
Kela drug reimbursment
Venetoclax
31.9
21.6
28
9
JN4BD
NOMESCO Finland
Extensive body CT
2.5
21.2
146
635
TPH00
NOMESCO Finland
Phlebotomy
19.9
20.9
31
16
H02AB06
ATC
prednisolone; systemic
1.9
20.9
506
3525
9860/3-C42.1
ICD-O-3
Myeloid leukemia, NOS, of bone marrow
+∞
20.9
20
*
TAB00
NOMESCO Finland
Lumbar puncture
3.7
20.7
67
189
GD1AD
NOMESCO Finland
Thorax CT examination
3.1
20.7
92
318
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
214.3
20.6
21
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
20.3
379
2424
A07AA02
ATC
nystatin; oral
3.1
20.3
91
316
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.4
19.9
51
121
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
32.0
19.3
25
8
ZXD05
NOMESCO Finland
Urgent procedure
1.9
18.9
332
2071
170
Kela drug reimbursment
Bosutinib
+∞
18.8
18
*
C92.3
ICD-10 Finland
Myeloid sarcoma
+∞
18.8
18
*
9873/3-C42.1
ICD-O-3
Acute myeloid leukemia without maturation of bone marrow
+∞
18.8
18
*
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
18.8
18
*
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
18.8
18
*
1518, ,
Kela drug reimbursment
27.3
17.9
24
9
9983/3-C42.1
ICD-O-3
Myelodysplastic syndrome with excess blasts of bone marrow
183.1
17.6
18
*
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
29.4
17.5
23
8
306
Kela drug reimbursment
Erythropoietin and darbepoetin
21.3
17.4
25
12
A03FA01
ATC
metoclopramide; systemic, rectal
2.0
17.2
245
1420
9920/3-C42.1
ICD-O-3
Therapy-related myeloid neoplasm of bone marrow
+∞
16.7
16
*
1DB06, ,
NOMESCO Finland
+∞
16.7
16
*
J05AX18
ATC
letermovir; oral
+∞
16.7
16
*
WZC00
NOMESCO Finland
Treatment plan or consultation
1.8
16.6
358
2362
C03CA01
ATC
furosemide; systemic
1.8
16.1
380
2570
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.5
16.0
39
89
ZX121
NOMESCO Finland
Central venous catheter
19.6
15.6
23
12
D64.8
ICD-10 Finland
Other specified anaemias
5.1
15.5
33
67
2AX04, ,
NOMESCO Finland
162.4
15.5
16
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
15.2
245
1470
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
20.4
15.1
22
11
360
Kela drug reimbursment
Bosutinib
+∞
14.6
14
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
14.6
14
*
9895/3-C42.1
ICD-O-3
Acute myeloid leukemia with myelodysplasia-related changes of bone marrow
+∞
14.6
14
*
D46.3
ICD-10 Finland
Refractory anemia with excess of blasts with transformation
81.3
14.6
16
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
14.3
396
2779
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
14.1
98
426
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
6.8
14.1
22
33
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
5.5
14.1
27
50
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
30.5
13.9
18
6
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
24.2
13.8
19
8
SPAT1088
SPAT
Blood transfusion
13.0
13.4
23
18
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.5
13.3
85
355
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
13.3
130
653
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.6
13.2
43
122
5BA08, ,
NOMESCO Finland
12.5
12.6
22
18
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
12.6
128
651
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
32.5
12.6
16
5
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
32.5
12.6
16
5
9874/3-C42.1
ICD-O-3
Acute myeloid leukemia with maturation of bone marrow
+∞
12.5
12
*
1BC07, ,
NOMESCO Finland
+∞
12.5
12
*
L01EA04
ATC
bosutinib; oral
+∞
12.5
12
*
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
12.5
12
*
9867/3-C42.1
ICD-O-3
Acute myelomonocytic leukemia, NOS, of bone marrow
+∞
12.5
12
*
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
131.6
12.5
13
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
12.4
103
483
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
12.3
73
294
XG410
NOMESCO Finland
Flow-volume spirometry
3.0
12.3
56
196
A02BC01
ATC
omeprazole; systemic
1.7
12.2
285
1893
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
5.1
12.0
25
50
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
13.6
12.0
20
15
A01AB04
ATC
amphotericin B; local oral
2.7
11.8
65
252
B02AA02
ATC
tranexamic acid; systemic
2.0
11.8
129
675
ZX108
NOMESCO Finland
Inhalation
9.8
11.8
23
24
6BA02, ,
NOMESCO Finland
30.4
11.7
15
5
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
65.7
11.6
13
*
L03AA13
ATC
pegfilgrastim; parenteral
2.8
11.5
58
215
C92
ICD-10 Finland
Myeloid leukaemia
+∞
11.5
11
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
11.1
205
1271
D11AH01
ATC
tacrolimus; topical
11.3
11.1
20
18
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
11.0
209
1305
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
14.1
11.0
18
13
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
5.0
10.8
23
47
A04AA02
ATC
granisetron; systemic, transdermal
2.4
10.6
75
329
J01MA02
ATC
ciprofloxacin; systemic
1.6
10.6
395
2929
1DB07, ,
NOMESCO Finland
+∞
10.4
10
*
L01XE14
ATC
[U] bosutinib
+∞
10.4
10
*
9801/3-C42.1
ICD-O-3
Acute leukemia, NOS, of bone marrow
+∞
10.4
10
*
373
Kela drug reimbursment
Ponatinib
+∞
10.4
10
*
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
10.4
10
*
L03AA04, ,
ATC
19.0
10.3
15
8
A02BC02
ATC
pantoprazole; systemic
1.6
10.2
651
5422
RS220, ,
NOMESCO Finland
5.1
10.1
21
42
C82.1
ICD-10 Finland
Follicular lymphoma grade II
9.3
10.0
20
22
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
14.8
10.0
16
11
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.3
10.0
75
337
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.1
9.9
40
131
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
9.8
289
2018
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
9.8
68
295
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
20.3
9.8
14
7
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.9
9.7
46
165
B01AB05
ATC
enoxaparin; parenteral
1.6
9.6
310
2211
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
8.5
9.6
20
24
SPAT1074
SPAT
Venesection
9.2
9.5
19
21
ZXE00
NOMESCO Finland
One hour or less
1.5
9.5
364
2700
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.0
9.4
41
140
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
9.4
9
*
20500
ICD-8 Finland
Myeloid leukaemia, Acute
+∞
9.4
9
*
1529, ,
Kela drug reimbursment
+∞
9.4
9
*
A40.9
ICD-10 Finland
Streptococcal sepsis, unspecified
21.9
9.4
13
6
J01FF01
ATC
clindamycin; systemic
1.6
9.3
261
1798
Z2446
NOMESCO Finland
Social worker
2.2
9.3
76
354
D75.2
ICD-10 Finland
Essential thrombocytosis
7.4
9.2
21
29
ZX100
NOMESCO Finland
Oral
4.2
9.2
24
58
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
9.1
106
566
A98
ICPC
Health maint/preventive medicine
0.6
9.0
770
8461
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
7.5
9.0
20
27
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
18.8
8.9
13
7
K61.0
ICD-10 Finland
Anal abscess
4.5
8.9
21
47
A07AA09
ATC
vancomycin; oral
4.5
8.9
21
47
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.1
8.8
36
119
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
8.6
468
3711
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
8.6
212
1412
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.9
8.5
25
66
B74
ICPC
Malignant neoplasm blood other
27.8
8.5
11
*
174
Kela drug reimbursment
Ruxolitinib
27.8
8.5
11
*
J02AC05
ATC
isavuconazole; systemic
90.8
8.4
9
*
E89.4
ICD-10 Finland
Postprocedural ovarian failure
90.8
8.4
9
*
L03AA10
ATC
lenograstim; parenteral
+∞
8.3
8
*
9800/3-C42.1
ICD-O-3
Leukemia, NOS, of bone marrow
+∞
8.3
8
*
T86.9
ICD-10 Finland
Failure and rejection of unspecified transplanted organ and tissue
+∞
8.3
8
*
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
10.9
8.3
15
14
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.3
8.3
30
92
C91.7
ICD-10 Finland
Other lymphoid leukaemia
33.6
8.1
10
*
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
11.8
8.1
14
12
N05CF01
ATC
zopiclone; oral
1.5
8.1
318
2354
H02AB02
ATC
dexamethasone; systemic
1.8
8.0
116
665
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
7.9
105
586
B02.9
ICD-10 Finland
Zoster without complication
2.1
7.8
72
353
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
15.2
7.7
12
8
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
25.2
7.6
10
*
L04AX03
ATC
methotrexate; systemic
1.9
7.5
89
478
L01XX35
ATC
anagrelide; oral
80.7
7.4
8
*
D46.1
ICD-10 Finland
Refractory anaemia with ring sideroblasts
80.7
7.4
8
*
V03AC03
ATC
deferasirox; oral
80.7
7.4
8
*
A12BA01
ATC
potassium chloride; oral
2.3
7.4
58
266
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
7.7
7.4
16
21
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.2
7.4
58
267
L01EA05
ATC
ponatinib; oral
+∞
7.3
7
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
7.1
113
667
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
4.1
7.1
19
47
RS221, ,
NOMESCO Finland
4.2
7.0
18
43
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.8
7.0
33
119
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.3
6.9
49
216
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
6.8
6.8
16
24
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
16.8
6.8
10
6
1XC02, ,
NOMESCO Finland
7.2
6.7
15
21
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
22.7
6.7
9
*
374
Kela drug reimbursment
Ruxolitinib
22.7
6.7
9
*
L01AA01
ATC
cyclophosphamide; systemic
7.9
6.6
14
18
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.5
326
2509
TPX15
NOMESCO Finland
Removal of vascular injection port
10.1
6.5
12
12
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
6.9
6.5
15
22
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4.0
6.5
18
46
G03DC03
ATC
lynestrenol; oral
4.0
6.5
18
46
1BC01, ,
NOMESCO Finland
70.3
6.4
7
*
C91.2
ICD-10 Finland
Subacute lymphocytic leukemia
70.3
6.4
7
*
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.4
402
3222
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
6.4
66
339
Z3231
NOMESCO Finland
Registered nurse
1.5
6.3
257
1901
M87.3
ICD-10 Finland
Other secondary osteonecrosis
18.1
6.3
9
5
B01AC14
ATC
[U] anagrelide
+∞
6.3
6
*
C94.0
ICD-10 Finland
Acute erythroid leukaemia
+∞
6.3
6
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
6.3
6
*
C421, 9877, 3
ICD-O-3
+∞
6.3
6
*
C94.7
ICD-10 Finland
Other specified leukaemias
+∞
6.3
6
*
L01EJ01
ATC
ruxolitinib; oral
26.8
6.2
8
*
C95.1
ICD-10 Finland
Chronic leukaemia of unspecified cell type
26.8
6.2
8
*
L01XE18
ATC
[U] ruxolitinib
26.8
6.2
8
*
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.5
6.2
76
1315
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
6.2
48
220
PJA10
NOMESCO Finland
Exploration of lymph nodes
3.6
6.2
20
57
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.2
6.1
16
39
C07AB02
ATC
metoprolol; systemic
1.5
6.1
209
1493
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
10.1
6.0
11
11
K60.3
ICD-10 Finland
Anal fistula
3.3
6.0
22
68
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
5.2
6.0
17
33
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
349
144
36.58
307.65
4.8
1.5
—
—
—
0
0
602
972
13.93
307.65
18.1
3.9
297.67
251.37
u/l
2.33
592
912
448
754
9.91
282.19
7.0
2.7
64.80
69.84
e9/l
1.44
359
601
506
1016
9.01
271.44
7.2
2.7
1.81
1.79
%
0.14
489
914
225
154
18.53
260.91
10.7
6.7
364.18
482.00
iu/ml
0.22
40
21
217
141
19.35
258.30
1.5
1.4
111.37
104.42
u/ml
0.41
59
26
222
154
18.21
255.45
1.4
1.3
—
—
—
0
0
204
128
19.74
246.71
3.9
3.8
478.65
1987.47
u/ml
0.53
17
15
247
224
14.29
243.34
4.1
2.9
3.68
3.69
g/l
0.02
240
213
198
146
16.64
219.42
1.4
1.3
252.47
253.57
u/ml
0.01
127
82
348
595
8.41
210.31
3.0
2.9
9.58
11.01
g/l
5.34
335
542
187
6
384.68
191.46
1.1
1.0
—
—
—
0
0
451
1109
6.56
188.39
13.0
6.1
1.04
1.03
mmol/l
0.30
446
1016
176
141
14.92
185.15
3.9
1.7
—
—
—
0
0
176
141
14.92
185.15
3.9
1.7
—
—
—
0
0
327
595
7.66
184.65
11.7
4.0
1.27
0.54
%
7.24
261
205
202
207
11.96
181.67
4.1
1.7
—
—
—
0
0
289
476
8.12
178.44
1.6
1.7
1.13
1.43
g/l
1.02
277
435
201
213
11.54
176.43
3.8
1.7
—
—
—
0
0
95
19
55.11
166.39
1.3
1.1
—
—
—
0
0
154
124
14.48
160.94
9.7
3.8
1.33
1.30
%
0.02
145
113
196
232
10.25
158.12
1.7
1.7
—
—
—
0
0
309
626
6.68
154.85
12.8
4.3
0.34
0.13
%
1.68
244
211
459
1340
5.46
153.25
11.0
3.5
0.81
0.82
mmol/l
0.29
447
1250
161
154
12.26
150.80
4.2
1.7
—
—
—
0
0
229
396
7.19
132.82
1.8
2.0
1.42
1.57
g/l
1.09
202
350
558
2124
4.65
128.72
9.0
2.8
321.69
7774.53
umol/l
8.81
539
1831
77
21
39.62
125.06
1.7
1.4
—
—
—
0
0
130
121
12.19
123.38
8.5
6.4
10.01
11.78
mg/l
3.16
125
110
99
60
18.19
119.90
1.8
1.3
—
—
—
0
0
110
0
+∞
117.00
1.0
0.0
—
—
—
0
0
110
85
14.41
116.98
4.8
1.9
—
—
—
0
0
115
97
13.26
116.04
2.3
1.7
—
—
—
0
0
115
97
13.26
116.04
2.3
1.7
—
—
—
0
0
101
71
15.70
113.21
9.8
3.6
42.84
55.87
%
3.46
91
64
110
95
12.88
109.26
4.8
1.8
—
—
—
0
0
97
0
+∞
102.91
14.7
0.0
—
—
—
0
0
709
3677
4.14
96.65
23.3
5.8
2.34
2.86
%
8.14
694
3433
125
156
9.01
95.36
2.0
1.5
—
—
—
0
0
272
730
4.74
95.26
2.3
3.1
65.39
66.40
g/l
1.31
264
663
716
3772
4.12
94.54
23.8
6.0
31.42
27.10
%
13.23
700
3535
377
1312
4.00
92.67
4.7
2.1
29.07
29.82
s
1.65
368
1266
88
69
13.88
92.44
1.1
1.0
—
—
—
0
0
78
53
15.87
88.72
1.3
1.4
—
—
—
0
0
691
3714
3.75
84.76
21.3
5.7
49.46
57.73
%
34.64
674
3483
96
99
10.61
84.35
2.4
1.7
—
—
—
0
0
87
79
11.96
83.33
5.3
1.6
—
—
—
0
0
87
79
11.96
83.33
5.3
1.6
—
—
—
0
0
87
79
11.96
83.33
5.3
1.6
—
—
—
0
0
89
87
11.13
81.12
4.1
2.7
—
—
—
0
0
63
34
19.70
80.13
6.5
1.9
—
—
—
0
0
63
34
19.70
80.13
6.5
1.9
—
—
—
0
0
103
125
9.07
80.06
2.1
1.7
—
—
—
0
0
63
35
19.14
79.06
6.5
1.8
—
—
—
0
0
229
615
4.53
79.01
3.3
1.7
—
—
—
0
0
70
51
14.68
76.50
7.1
3.9
—
—
—
0
0
368
1438
3.46
73.23
4.3
1.9
—
—
—
0
0
65
45
15.37
73.02
6.4
1.7
—
—
—
0
0
65
45
15.37
73.02
6.4
1.7
—
—
—
0
0
96
123
8.52
71.29
1.9
1.5
—
—
—
0
0
106
157
7.43
69.47
1.3
1.2
151.21
32.97
u/l
3.48
95
140
75
74
10.87
67.76
1.6
1.7
—
—
—
0
0
744
4564
3.42
66.12
41.9
9.0
3.54
4.17
e9/l
2.17
696
4013
90
117
8.35
65.96
4.8
2.1
33.60
32.36
pg
1.41
90
117
59
44
14.18
63.50
1.5
1.7
—
—
—
0
0
59
44
14.18
63.50
1.5
1.7
—
—
—
0
0
240
773
3.76
63.37
8.9
7.8
8.29
10.33
mmol/l
4.64
234
731
706
4271
3.19
62.76
25.0
6.5
11.47
11.60
umol/l
0.12
688
4052
347
1419
3.21
62.54
1.6
1.5
2.28
2.53
g/l
1.68
297
864
44
20
22.96
59.95
8.5
1.8
—
—
—
0
0
111
204
5.99
58.85
1.5
2.0
24.70
12.20
mg/l
1.48
96
185
90
139
7.01
56.57
2.2
1.5
—
—
—
0
0
124
263
5.24
56.18
2.2
1.2
—
—
—
0
0
380
1722
2.94
56.08
3.2
1.7
3.04
1.25
mg/l
3.90
332
1342
84
124
7.30
55.01
2.1
1.5
—
—
—
0
0
42
21
20.83
54.97
1.8
1.4
—
—
—
0
0
271
1024
3.25
54.93
3.0
1.8
—
—
—
0
0
668
4117
2.85
53.59
19.6
7.2
1.21
1.21
mmol/l
0.94
581
3479
57
53
11.34
53.46
2.3
2.9
37.37
39.33
%
0.19
27
29
264
1024
3.14
50.77
3.1
1.8
—
—
—
0
0
127
303
4.65
49.85
3.3
3.0
—
—
—
0
0
247
933
3.18
49.59
13.2
2.8
7.62
8.92
umol/l
0.48
239
824
48
41
12.24
47.49
1.5
1.3
—
—
—
0
0
47
39
12.59
47.34
2.7
1.3
—
—
—
0
0
47
39
12.59
47.34
2.7
1.3
—
—
—
0
0
611
3757
2.60
46.52
16.6
6.4
1.20
1.21
mmol/l
1.54
587
3398
51
51
10.48
45.45
2.6
1.3
—
—
—
0
0
50
51
10.26
43.92
2.6
1.3
—
—
—
0
0
134
379
3.93
41.76
3.1
2.0
6.18
2.20
ug/l
0.65
128
333
288
1323
2.65
39.20
2.4
2.6
15.63
12.66
umol/l
7.11
280
1238
41
37
11.51
39.09
1.1
1.5
—
—
—
0
0
261
1147
2.72
38.76
2.5
2.6
30.83
22.38
%
8.39
215
984
574
3614
2.37
38.73
14.8
4.9
33.93
35.14
g/l
5.21
561
3366
268
1222
2.63
36.74
2.4
2.6
2.13
2.31
g/l
6.41
257
1142
372
2024
2.33
34.25
10.5
4.0
84.74
87.76
%
1.46
362
1978
74
159
4.94
32.71
8.0
3.5
48.91
58.55
%
5.56
74
159
359
1955
2.30
32.69
12.0
2.4
—
—
—
0
0
570
3741
2.21
32.67
12.1
2.6
—
—
—
0
0
100
281
3.84
31.22
2.5
4.0
42.80
78.35
mg/l
0.85
85
230
99
277
3.85
31.10
2.0
3.9
42.57
1.84
ratio
—
5
25
36
38
9.79
30.76
2.6
2.2
—
—
—
0
0
37
41
9.33
30.51
1.2
1.1
—
—
—
0
0
48
73
6.85
30.42
1.2
1.1
—
—
—
0
0
98
281
3.76
29.69
2.6
4.0
26.09
44.85
mg/l
1.07
83
233
507
3294
2.09
28.43
4.2
2.8
509.08
145.26
ug/l
8.67
488
3004
74
179
4.38
28.25
3.9
1.4
—
—
—
0
0
53
101
5.48
26.78
4.8
1.5
—
—
—
0
0
139
529
2.89
26.45
3.0
1.6
—
—
—
0
0
105
341
3.32
26.24
6.4
1.9
—
—
—
0
0
53
103
5.38
26.22
4.8
1.5
—
—
—
0
0
53
103
5.38
26.22
4.8
1.5
—
—
—
0
0
53
103
5.38
26.22
4.8
1.5
—
—
—
0
0
53
103
5.38
26.22
4.8
1.5
—
—
—
0
0
53
104
5.32
25.94
4.8
1.5
—
—
—
0
0
103
334
3.32
25.80
1.8
2.6
3.46
3.54
g/l
0.20
98
302
103
335
3.31
25.67
1.8
2.6
—
—
—
0
0
103
335
3.31
25.67
1.8
2.6
6.85
7.34
g/l
2.08
98
302
98
311
3.38
25.40
1.8
2.7
9.50
10.86
g/l
1.93
93
277
656
4826
2.03
24.57
11.8
5.1
6.77
6.74
mmol/l
0.15
638
4541
32
11
29.99
24.19
1.3
4.0
—
—
—
0
0
33
46
7.38
22.57
1.5
5.7
—
33.58
—
0
12
94
315
3.19
22.25
2.8
1.7
—
—
—
0
0
353
2155
1.98
22.09
2.5
2.2
2.98
3.13
mg/l
0.48
306
1824
403
2576
1.94
22.02
6.4
3.3
34.70
33.39
u/l
0.20
388
2450
93
312
3.18
21.97
1.8
2.7
3.04
2.97
g/l
0.22
88
279
29
10
29.81
21.95
1.4
1.7
—
—
—
0
0
67
200
3.52
19.04
1.9
1.4
—
—
—
0
0
439
2987
1.83
18.99
4.6
3.4
—
—
—
0
0
66
206
3.36
17.51
1.3
1.3
—
—
—
0
0
383
2568
1.79
16.88
3.7
2.5
51.69
90.92
u/l
0.68
361
2368
56
164
3.56
16.39
1.4
1.6
—
—
—
0
0
50
136
3.82
16.29
2.6
2.1
22463.57
2471.22
u/l
0.79
15
47
544
4061
1.74
16.26
14.8
17.3
1.23
1.31
inr
1.46
166
1175
320
2058
1.81
16.05
1.9
1.6
19.11
20.62
nmol/l
1.06
300
1740
35
73
4.93
15.99
2.4
1.7
—
—
—
0
0
55
162
3.53
15.96
1.2
1.3
266.47
239.92
miu/ml
0.13
12
75
117
522
2.40
15.91
1.6
1.5
—
—
—
0
0
78
285
2.88
15.84
1.6
3.1
0.32
1.51
g/l
2.87
71
253
25
38
6.72
15.80
2.8
2.4
1235.36
1007.37
u/ml
0.31
25
38
752
6215
1.83
15.22
31.5
7.7
82.62
79.43
u/l
1.15
738
5813
271
1686
1.83
14.99
1.9
1.8
1240.98
1186.51
nmol/l
0.42
239
1261
40
100
4.12
14.63
1.1
1.0
—
—
—
0
0
72
266
2.84
14.33
1.5
2.7
37.32
37.61
g/l
0.14
67
233
25
21
12.18
14.13
1.6
1.2
—
—
—
0
0
25
22
11.62
13.84
1.3
1.3
—
—
—
0
0
466
3439
1.66
13.68
2.3
2.0
91.39
94.24
pmol/l
0.63
333
1780
22
37
6.06
12.63
10.5
3.6
227.91
208.11
u/l
0.37
22
37
252
1621
1.74
12.10
5.0
4.0
127.64
339.31
ng/l
2.22
212
1325
371
2652
1.63
11.91
3.5
3.2
1437.23
1682.44
ng/l
0.44
347
2280
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
73
300
2.55
11.81
3.3
2.8
0.32
0.37
u/ml
0.49
40
167
113
562
2.14
11.80
6.0
3.9
0.87
1.98
mmol/l
2.75
89
414
25
51
5.00
11.73
2.4
1.6
—
—
—
0
0
25
51
5.00
11.73
2.4
1.6
—
—
—
0
0
15
5
30.41
11.66
1.7
6.4
—
—
—
0
0
117
597
2.09
11.42
6.1
3.8
5.05
5.15
kpa
0.78
112
573
27
61
4.52
11.25
2.3
1.5
—
—
—
0
0
49
168
3.01
11.17
3.1
1.2
8.31
39.16
e6/l
0.50
39
134
49
168
3.01
11.17
3.1
1.3
42.54
855.09
e6/l
0.69
41
139
354
2541
1.61
10.97
4.6
3.4
273.80
96.10
e6/l
0.34
282
2004
41
130
3.25
10.65
1.2
1.1
—
—
—
0
0
381
2807
1.58
10.45
5.5
3.5
2.31
2.35
mmol/l
5.78
353
2457
50
187
2.76
9.77
2.6
1.2
497.94
517.46
mg/l
0.13
50
177
345
2518
1.56
9.69
3.7
2.1
159.17
247.36
u/l
1.63
333
2362
137
785
1.86
9.54
2.7
2.4
0.21
0.21
g/l
0.10
123
732
9
0
+∞
9.39
5.3
0.0
—
—
—
0
0
23
54
4.34
9.15
3.3
1.6
—
—
—
0
0
18
21
8.71
8.82
2.3
1.6
—
—
—
0
0
204
1345
1.65
8.64
4.4
3.0
2.54
2.20
e6/l
0.20
114
769
15
13
11.69
8.58
1.3
1.0
—
—
—
0
0
47
183
2.65
8.52
1.4
1.3
—
—
—
0
0
47
183
2.65
8.52
1.4
1.3
—
—
—
0
0
701
7820
0.66
8.04
5.2
5.1
2.52
2.67
mmol/l
4.95
662
7099
620
5258
1.47
7.77
5.8
4.7
145.06
2821.83
e6/l
1.98
17
100
311
2310
1.50
7.71
4.6
3.2
0.57
0.49
e6/l
0.17
243
1787
21
54
3.95
7.46
1.3
1.2
—
—
—
0
0
7
0
+∞
7.30
3.0
0.0
8.23
—
ng/l
—
7
0
55
250
2.27
7.19
1.5
1.6
—
—
—
0
0
43
178
2.48
6.93
2.5
1.4
12.79
8.30
u/l
0.74
37
140
800
8626
0.65
6.82
73.2
23.0
116.35
134.94
g/l
101.33
789
8470
800
8624
0.65
6.77
72.8
22.9
3.87
4.47
e12/l
84.02
782
8357
124
763
1.71
6.75
3.9
3.0
227.76
230.98
ng/l
0.04
116
702
800
8622
0.65
6.73
72.9
22.9
192.09
244.52
e9/l
37.97
784
8383
800
8619
0.65
6.66
73.2
23.0
35.17
39.97
%
64.88
743
8004
45
195
2.37
6.58
2.0
2.1
118.00
128.77
g/l
1.41
34
146
155
1022
1.61
6.46
9.7
8.1
4.92
5.11
kpa
1.31
148
977
155
1023
1.61
6.43
9.7
8.1
11.69
11.86
kpa
0.19
147
980
130
825
1.66
6.30
5.1
4.0
2.17
2.13
mmol/l
0.04
109
674
6
0
+∞
6.25
10.8
0.0
—
—
—
0
0
6
0
+∞
6.25
1.2
0.0
—
—
—
0
0
200
1411
1.52
6.18
4.1
2.8
1.53
1.03
e6/l
0.68
115
827
16
39
4.15
6.10
3.9
1.2
19.51
6.15
ug/l
1.15
16
33
153
1021
1.59
6.05
10.2
8.1
1.62
1.34
mmol/l
0.34
118
802
49
229
2.20
6.04
1.4
1.6
0.15
26.78
iu/ml
—
9
45
17
33
5.22
6.03
1.8
1.2
—
—
—
0
0
689
7593
0.71
5.87
4.9
4.5
1.29
1.44
mmol/l
17.90
646
6893
20
62
3.27
5.47
1.5
1.4
13.60
14.56
u/l
0.18
20
57
41
187
2.24
5.38
2.3
1.4
19.68
24.54
iu/l
0.57
33
159
11
15
7.40
5.15
3.8
1.0
—
—
—
0
0
662
5884
1.37
5.10
6.1
4.1
19.29
12.91
mm/h
11.66
624
5383
236
1787
1.42
4.99
3.4
2.7
5.38
5.08
e6/l
0.13
222
1617
26
101
2.62
4.83
1.6
1.3
74070.19
39367.18
e6/l
0.23
16
55
28
113
2.52
4.82
1.6
1.4
2072.05
1486.58
e6/l
0.50
22
76
395
3279
1.34
4.67
3.8
3.9
62.29
53.08
ng/l
0.10
311
2411
31
134
2.36
4.63
1.2
1.2
—
—
—
0
0
59
327
1.85
4.61
1.7
2.0
37.06
39.22
u/l
0.36
51
286
7
5
14.08
4.58
2.6
2.0
1.29
1.90
%
—
7
5
704
7646
0.74
4.56
5.1
4.6
4.28
4.56
mmol/l
9.44
670
6992
68
396
1.77
4.53
3.3
3.3
4.46
4.48
pmol/l
0.05
61
340
10
15
6.72
4.47
1.0
1.3
—
—
—
0
0
664
7254
0.75
4.30
5.9
6.1
39.70
40.31
mmol/mol
0.96
621
6649
8
9
8.95
4.28
1.0
1.2
—
—
—
0
0
110
740
1.55
4.20
2.6
2.3
29.49
100.18
u/l
0.56
97
629
12
28
4.32
3.82
1.3
1.1
—
—
—
0
0
14
38
3.72
3.80
1.1
1.0
—
—
—
0
0
12
29
4.18
3.71
1.2
1.0
—
—
—
0
0
43
237
1.85
3.48
1.4
1.5
242.19
280.09
ug/g
0.60
26
139
706
7577
0.77
3.40
6.0
4.8
6.11
6.02
mmol/l
1.03
654
6801
13
42
3.12
3.38
1.3
1.1
—
—
—
0
0
7
11
6.40
3.19
2.1
5.1
—
—
—
0
0
21
91
2.34
3.19
1.4
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
44
2.98
3.14
1.3
1.1
—
—
—
0
0
373
3200
1.26
3.13
2.8
2.3
76.02
77.77
nmol/l
0.58
350
2806
37
202
1.86
3.11
1.6
1.6
—
—
—
0
0
442
3875
1.25
3.05
4.1
3.9
0.00
0.00
estimate
-0.00
85
703
12
36
3.36
3.02
3.8
1.3
—
—
—
0
0
21
94
2.26
2.98
4.2
4.0
—
—
—
0
0
33
177
1.89
2.94
2.8
2.4
15.20
15.88
%
0.39
23
91
14
52
2.72
2.89
1.4
1.1
27.14
42.61
mg/l
1.15
14
42
6
9
6.70
2.87
1.0
1.3
—
—
—
0
0
435
3827
1.24
2.86
5.6
5.2
0.00
0.00
estimate
0.50
90
719
11
33
3.36
2.81
2.4
1.3
57.27
70.52
mg/l
0.31
11
25
224
1828
1.29
2.78
1.6
1.7
66667140.07
17667316.24
pmol/l
0.33
186
1483
788
8284
0.77
2.74
36.9
10.8
27.18
26.28
u/l
0.88
767
7955
12
40
3.02
2.70
1.3
1.6
2.75
3.25
ug/l
—
7
32
433
3828
1.23
2.67
4.1
3.9
0.00
0.00
estimate
0.50
93
770
90
642
1.44
2.65
3.4
2.2
13.06
12.95
nmol/l
0.05
84
574
17
74
2.32
2.59
2.1
2.2
—
—
—
0
0
18
81
2.24
2.55
1.3
2.3
—
—
—
0
0
13
51
2.57
2.45
1.3
1.1
236.15
244.73
mg/l
0.07
13
44
20
97
2.08
2.38
1.2
1.2
1.60
2.54
u/ml
—
5
28
62
420
1.51
2.38
5.2
4.0
44.86
47.59
%
0.35
62
414
16
73
2.21
2.22
1.3
1.2
10.75
13.71
u/l
0.39
16
66
5
9
5.58
2.21
1.2
1.1
—
—
—
0
0
8
24
3.35
2.18
1.0
1.1
—
—
—
0
0
693
7337
0.82
2.17
5.2
4.1
1.53
1.29
mmol/l
3.98
653
6621
101
764
1.36
2.15
2.2
2.6
4.58
7.10
ug/l
1.68
89
675
482
4376
1.19
2.10
3.4
2.7
—
—
—
0
0
698
7370
0.83
2.03
40.7
14.6
76.97
78.16
ml/min/173m2
0.68
611
6089
47
312
1.53
2.01
2.7
2.2
174.35
544.72
ug/l
1.40
42
295
216
2532
0.81
1.97
3.8
4.4
21.22
21.40
%
0.06
103
1252
85
637
1.37
1.94
3.9
4.2
82.03
92.27
ng/l
0.72
80
560
245
2110
1.21
1.85
4.1
4.2
0.00
0.01
estimate
0.88
83
694
11
46
2.41
1.85
1.9
1.6
1.50
3.12
u/field
—
6
34
37
557
0.65
1.81
1.8
1.7
—
—
—
0
0
16
80
2.02
1.80
1.3
1.1
—
—
—
0
0
73
541
1.38
1.80
14.1
9.6
1.49
1.41
%
0.37
73
536
150
1807
0.80
1.76
2.8
3.1
0.71
0.78
ug/l
0.63
93
1215
6
18
3.35
1.75
1.0
1.2
—
—
—
0
0
42
282
1.51
1.74
6.3
3.7
3.77
3.94
mmol/l
1.41
42
277
5
13
3.86
1.71
3.4
1.5
—
—
—
0
0
62
451
1.40
1.71
4.0
3.6
24.81
25.26
mmol/l
0.49
62
436
36
237
1.54
1.64
1.2
1.2
—
—
—
0
0
11
49
2.26
1.64
1.1
1.0
—
—
—
0
0
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
36
239
1.53
1.59
1.2
1.2
—
—
—
0
0
108
865
1.28
1.58
2.0
2.2
169.41
133.36
ug/g
0.43
82
677
38
256
1.50
1.57
1.5
1.5
1.22
1.16
g/l
0.48
38
241
18
101
1.80
1.49
1.2
1.2
3.83
5.81
u/ml
—
6
48
49
352
1.41
1.48
1.4
1.3
—
—
—
0
0
17
94
1.82
1.48
1.0
1.1
123.24
116.10
%
0.36
17
88
28
179
1.58
1.47
1.3
1.3
—
—
—
0
0
11
53
2.09
1.39
1.0
1.3
—
—
—
0
0
18
104
1.74
1.37
1.1
1.1
—
—
—
0
0
24
151
1.60
1.35
1.1
1.2
—
29.12
—
0
12
11
54
2.05
1.33
1.0
1.1
—
—
—
0
0
11
54
2.05
1.33
1.0
1.1
—
—
—
0
0
39
542
0.71
1.32
1.8
1.9
—
—
—
0
0
6
24
2.51
1.30
1.0
1.1
—
—
—
0
0
185
1605
1.19
1.30
3.5
3.1
2.45
2.45
mmol/l
0.03
173
1423
5
18
2.79
1.28
1.4
2.4
—
—
—
0
0
11
55
2.01
1.27
1.0
1.1
—
—
—
0
0
11
55
2.01
1.27
1.0
1.1
—
—
—
0
0
11
55
2.01
1.27
1.0
1.1
—
—
—
0
0
680
7097
0.87
1.26
5.2
4.6
2.00
2.12
mu/l
0.31
634
6388
16
92
1.75
1.25
1.8
1.3
—
—
—
0
0
27
179
1.52
1.24
3.0
3.9
38.51
26.00
mg/l
1.30
19
119
6
25
2.41
1.24
1.2
1.1
—
—
—
0
0
6
25
2.41
1.24
1.2
1.1
—
—
—
0
0
6
25
2.41
1.24
1.0
1.1
—
—
—
0
0
8
36
2.23
1.24
1.1
1.3
—
—
—
0
0
532
5001
1.14
1.23
4.2
3.2
73.03
51.97
u/l
2.59
500
4623
183
2088
0.85
1.22
2.3
1.6
1.85
1.36
mmol/l
2.24
165
1731
16
93
1.73
1.21
1.6
1.4
6.28
6.39
mmol/l
0.07
16
88
13
71
1.84
1.19
1.8
2.1
0.83
2.00
u/field
—
6
31
6
26
2.32
1.19
1.0
1.2
—
—
—
0
0
6
26
2.32
1.19
1.2
1.2
—
—
—
0
0
45
599
0.74
1.18
1.9
2.0
—
—
—
0
0
790
8145
0.86
1.17
54.5
18.7
3.98
3.99
mmol/l
0.67
778
7916
5
20
2.51
1.15
7.4
2.1
81.40
118.45
ng/l
—
5
14
28
192
1.47
1.12
1.5
1.2
—
—
—
0
0
10
52
1.93
1.06
1.0
1.3
—
—
—
0
0
7
34
2.07
1.03
2.3
4.4
—
—
—
0
0
137
1184
1.18
1.03
1.2
1.2
1.53
11.99
u/ml
5.85
46
429
108
914
1.20
1.02
3.4
4.1
14.27
24.85
ug/l
0.35
84
761
233
2576
0.88
1.01
3.1
3.2
7.60
7.52
mmol/l
0.09
204
2131
23
155
1.50
1.01
1.2
1.2
—
8.77
—
0
12
290
3161
0.88
1.01
4.3
5.1
3.80
2.85
ug/l
0.20
264
2803
129
1111
1.18
1.01
1.5
1.4
—
—
—
0
0
791
8131
0.87
0.99
49.3
18.5
139.27
139.65
mmol/l
4.20
778
7908
26
182
1.44
0.96
1.1
1.1
—
—
—
0
0
29
208
1.41
0.95
1.2
1.2
—
17.28
—
0
9
19
125
1.53
0.94
1.2
1.1
—
—
—
0
0
235
2583
0.88
0.93
3.9
3.8
12.37
9.53
mg/mmol
0.37
157
1612
31
227
1.38
0.91
1.4
1.4
—
—
—
0
0
9
155
0.58
0.88
1.3
1.5
—
—
—
0
0
17
112
1.53
0.85
1.0
1.1
—
13.09
—
0
7
23
162
1.43
0.85
1.2
1.1
—
—
—
0
0
13
80
1.63
0.85
1.0
1.3
—
—
—
0
0
15
96
1.57
0.84
1.0
1.1
—
—
—
0
0
6
31
1.94
0.84
3.3
1.7
30.67
54.39
ug/l
—
6
31
141
1592
0.87
0.84
1.3
1.2
1.64
1.81
u/ml
0.09
36
425
102
877
1.18
0.84
5.7
3.7
—
—
—
0
0
28
205
1.38
0.84
2.6
3.3
0.77
0.84
nmol/l
0.35
18
163
8
46
1.74
0.82
2.0
2.2
—
—
—
0
0
322
2998
1.11
0.81
4.2
4.1
—
—
—
0
0
0
26
0.00
0.78
0.0
1.1
—
314.18
—
0
17
139
1234
1.15
0.77
1.2
1.3
25.01
34.84
iu/ml
0.77
50
386
6
34
1.77
0.76
1.0
1.1
118.97
273.23
iu/ml
—
6
34
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
51
416
1.24
0.73
1.7
1.2
485.52
261.22
u/ml
0.46
42
374
116
1024
1.15
0.71
3.5
4.6
29.14
32.16
%
2.34
94
674
225
2439
0.90
0.71
3.3
3.2
2629.00
296.62
mg/l
2.41
165
1560
26
196
1.34
0.68
1.2
1.2
—
2.84
—
0
19
31
241
1.30
0.66
1.4
1.9
—
—
—
0
0
27
349
0.77
0.65
1.1
1.0
—
—
—
0
0
26
199
1.31
0.62
1.2
1.2
—
6.54
—
0
27
11
71
1.56
0.62
2.4
2.3
856.20
640.65
ml
—
5
43
10
63
1.59
0.62
1.0
1.0
—
—
—
0
0
75
651
1.16
0.59
4.3
2.8
62.54
63.33
ml/min/173m2
0.06
39
283
6
39
1.54
0.53
1.8
1.1
231.67
497.91
u/l
—
6
34
5
81
0.62
0.46
1.2
1.5
—
—
—
0
0
8
119
0.67
0.46
1.1
1.1
1.49
1.52
g/l
—
8
107
97
879
1.11
0.44
1.5
1.4
—
—
—
0
0
6
91
0.66
0.42
1.2
1.5
—
—
—
0
0
5
32
1.57
0.42
1.8
2.0
74.20
45.66
umol/l
—
5
25
189
1775
1.08
0.41
4.0
4.2
1.01
1.02
kg/l
1.92
28
260
11
79
1.40
0.41
1.0
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
111
1020
1.10
0.40
11.5
7.9
—
—
—
0
0
10
73
1.37
0.34
1.0
1.1
82.70
97.51
%
—
10
68
6
44
1.37
0.34
2.0
1.4
—
—
—
0
0
10
74
1.35
0.32
1.0
1.1
—
—
—
0
0
7
56
1.25
0.29
1.3
1.6
78.43
83.91
umol/l
—
7
56
16
130
1.23
0.29
1.2
1.6
—
—
—
0
0
14
173
0.81
0.28
1.4
1.4
—
—
—
0
0
5
72
0.69
0.26
1.2
1.6
—
—
—
0
0
6
81
0.74
0.24
1.2
1.5
—
—
—
0
0
6
81
0.74
0.24
1.2
1.5
—
—
—
0
0
790
7819
1.05
0.23
54.4
15.7
26.77
25.95
mg/l
0.29
734
6279
12
98
1.23
0.21
1.4
1.2
0.48
0.61
nmol/l
1.19
12
90
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
2.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
24
270
0.89
0.19
2.0
2.1
—
—
—
0
0
10
81
1.24
0.18
1.0
1.1
—
—
—
0
0
6
53
1.13
0.18
2.0
2.1
14.03
13.13
%
—
6
53
13
152
0.85
0.17
1.5
1.4
—
—
—
0
0
18
160
1.13
0.14
2.6
1.9
175.50
225.78
pmol/l
2.21
18
150
27
248
1.09
0.12
1.7
1.7
—
—
—
0
0
5
47
1.06
0.09
2.2
1.4
152.54
178.42
pmol/l
—
5
47
5
60
0.83
0.08
1.4
1.5
—
—
—
0
0
46
441
1.05
0.07
1.1
1.2
48.99
123.51
iu/ml
2.62
17
168
24
226
1.06
0.06
2.4
2.3
407.33
97.83
ug/min
0.42
12
139
585
5822
1.01
0.05
4.2
3.8
14.94
14.93
pmol/l
0.03
545
5202
23
218
1.06
0.05
1.8
2.0
—
—
—
0
0
86
846
1.02
0.03
1.5
1.8
1.58
1.51
%
0.32
72
732
22
216
1.02
0.00
2.9
1.8
43.23
40.95
nmol/l
0.11
22
206
21
208
1.01
0.00
1.4
1.6
19301.69
17722.62
e6/l
0.08
13
151
6
69
0.87
-0.00
1.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
384.80
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
69
0.87
-0.00
1.2
1.0
326.17
279.27
mg/l
—
6
60
6
63
0.95
-0.00
2.2
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_MYELOID_LEUKAEMIA – Myeloid leukaemia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).